Medical Monitoring | Medical XPRT
Articles & Whitepapers
-
How can Nuvonis help to fight the SARS-CoV-2 pandemics?
At the end of the year 2019, a cluster of severe pneumonia of unknown cause was described in Wuhan (Eastern China) and a SARS-like acute respiratory distress syndrome (ARDS) was noted in these patients. Early in January 2020, sequencing revealed a novel coronavirus (now termed SARS-CoV-2) as the causal factor for the disease designated as COVID-19. The pandemic caused by the virus has unforeseen ...
-
hVIVO used Nuvonis’ GMP Vero cells to produce Novel SARS-CoV-2 virus for a human challenge model
One of the main benefits of using Nuvonis’ fully tested GMP Vero cells is the unparalleled speed towards clinical trials. A case example from one of our customers, hVIVO: ...
News
-
A Phase Ii Trial Of Onapristone In Combination With Fulvestrant For Patients With Er-Positive And Her2-Negative Metastatic Breast Cancer After Progression On Endocrine Therapy And Cdk 4/6 Inhibitors
Antiprogestins act as Progesterone Receptor (PgR) antagonists. Novel and promising class of drugs to overcome endocrine resistance associated with ESR1 mutations. SMILE STUDY is a multi-institutional phase II clinical trial to determine the ...
Equipment & Solutions
-
Showcase
Arc Lamp - Metal Halide Lamp for MS24/MS48 Light Sources
AL-1824 Arc Lamp assembly is a high-intensity metal-halide bulb that fits MS24 and MS48 metal halide light sources.
Upcoming Events
-
Showcase
HALO and HALO AI 3.6 Sneak Peek
A new version of HALO® and HALO AI are coming soon! In this half hour webinar, Donald Allen will discuss and demonstrate new features and functionalities in this software release and end with a Q/A session. This webinar will cover all of the features in the release while taking a deeper dive into multiplex workflows and membrane segmentation in HALO and HALO AI 3.6. Sign up for the upcoming ...